Image source: Getty
Continue Reading Below
What:Shares ofOraSure Technologies(NASDAQ: OSUR), a healthcare company focused on diagnostic products and specimen collection devices, are up 14% as of 11:45 a.m. EDT Wednesday after the company announced that it has won a new government contract.
So what:OraSure stated that it has been awarded a contract from the Department of Health and Human Services and BADRA to help fund the development of its rapid Zika virus test. The contract could be worth up to $16.6 million over a six-year period, which includes an upfront commitment of$7 million.
In response to winning the contract CEO Douglas Michels said, "We are grateful to BARDA for making this funding available as it will enable us to complete clinical and other activities required to obtain regulatory approvals for this product." He also added that a fast Zika antibody test would be an important tool in helping to address current and future outbreaks.
Traders appear to be encouraged by the announcements and are bidding up shares accordingly.
Now what: Wednesday's news is most certainly a welcome win for investors, as the recent news out of OraSure hasn't been universally positive.
In July shares took a dive after the company announced that its co-promotion partnership agreement withpharma giant AbbVie (NYSE: ABBV) would be terminated at the end of the year. That took the markets by surprise as the original deal was expected to run through the end of 2019. In addition, OraSure was set up to earn a total of $75 million in exclusivity payments from AbbVie through the life of the contract, but the early termination should greatly reduce that number.
Sales of the company's rapidHCV test grew by a strong 37% last quarter with AbbVie's help, so it's unclear if that strong growth rate will continue once the partnership ends. OraSure did state that it was free to seek other partnership arrangements, but so far no announcements have been made.
Still, Wednesday's news should help advance the company's Zika virus testing research, and it should be seen as a vote of confidence from the U.S. government on OraSure's capabilities and technology. Plus, a small cash infusion and the prospects of more coming in over time is never a bad thing. For that reason, it's hard to blame the markets for bidding up Wednesday.
A secret billion-dollar stock opportunity The world's biggest tech company forgot to show you something, but a few Wall Street analysts and the Fool didn't miss a beat: There's a small company that's powering their brand-new gadgets and the coming revolution in technology. And we think its stock price has nearly unlimited room to run for early in-the-know investors! To be one of them, just click here.
Brian Feroldi has no position in any stocks mentioned.Like this article? Follow him onTwitter where he goes by the handle@Longtermmindsetor connect with him on LinkedIn to see more articles like this.
The Motley Fool has no position in any of the stocks mentioned. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.